Peregrine accelerates Tarvacin development (Hepatitis C Infection)

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

HAART reduces liver-related death risk, but hepatitis C infection ...
Aidsmap, UK - Jan 18, 2006Highly active antiretroviral therapy (HAART) reduces the risk of liver-related death by 68%, although infection with both HIV and hepatitis C virus (HCV ...

Transgene Awarded EUR 1.3 M Grant for Hepatitis C Therapeutic ...
Canada NewsWire (press release), Canada - Jan 25, 2006... About Hepatitis C: Hepatitis C infection is a major public health problem with around 170 to 200 million people infected worldwide. ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006... Dr. McHutchison has published widely in the field of liver diseases and is the author of numerous articles and book chapters on chronic hepatitis C infection. ...